Scienmag
OCTOBER 26, 2020
NIA experts available to share context and insight on latest research shared at CTAD WHAT: National Institute on Aging (NIA) experts will be available to further explain and analyze some of the latest research as presented at the 13th Annual International Conference on Clinical Trials for Alzheimer’s Disease (CTAD).
Scienmag
OCTOBER 21, 2020
While FDA-approved technique is used to treat other medical conditions, this study examines its effects on cognitive function Credit: Image courtesy of Ricardo Carrasco III of Keck Medicine of USC LOS ANGELES — An estimated 5.5 Keck […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
JUNE 22, 2021
Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)
Scienmag
NOVEMBER 9, 2020
Credit: Insilico Tuesday, November 10, 2020 (9AM Beijing) – Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V.
pharmaphorum
NOVEMBER 22, 2021
In late 2006, BRAVEMIND was tested in San Diego, California, at the Naval Medical Center and Camp Pendleton, and good clinical data was obtained in the initial open clinical trials. Other groups started to adopt the platform, which led to more research as to its clinical efficacy. VR clinical trials.
Scienmag
DECEMBER 23, 2020
The Phase 3 clinical trial showed that the drug, called CC-486, significantly improved survival in older patients, over the age of 55, with AML A landmark paper published today in the New England Journal of Medicine describes the results from a global trial across 148 sites in 23 countries, showing a 30 per cent improvement […].
Scienmag
OCTOBER 19, 2020
Researchers recommend clinical trials to assess non-invasive ventilation for cancer, dementia patients near end of life More research is needed before a less invasive form of ventilation is used near the end of life for patients who have cancer and dementia, recommends the authors of a scientific paper published in JAMA Internal Medicine.
Expert insights. Personalized for you.
73 
Let's personalize your content